Table 2.

Endoscopy data and comparison between bleeding and non-rebleeding groups

Variables	No-rebleeding n = 1035 (88.5%)	Rebleeding n = 135 (11.5%)	P-value
Duodenal ulcer	475 (45.8%)	51 (3.7%)	0.075
Gastric ulcer	251 (24.2%)	33 (24.4%)	0.233
Esophageal varices	150 (14.4%)	27 (20%)	0.093
Gastric carcinoma	61 (5.8%)	12 (8.8)	0.176
Mallory–Weiss	41 (3.96%)	6 (4.4%)	0.788
Gastroduodenal anastomotic ulcer	22 (2.1%)	1 (0.7%)	0.276
Dieulafoy disease	12 (1.1%)	0	0.209
Esophageal carcinoma	9 (0.8%)	3 (2.2%)	0.142
Gastric stromal tumor	8 (0.7%)	0	0.305
Duodenal carcinoma	6 (0.5%)	2 (1.4%)	0.232
Endoscopic hemostasis
Mechanical therapy	427 (41.2%)	52 (38.5%)	0.543
Combination therapy	231 (22.3%)	39 (28.8%)	0.088
Injection therapy	229 (22.1%)	20 (14.8%)	0.051
Electric coagulation	148 (14.2%)	24 (17.7%)	0.283